Which are the symptoms of Von Hippel-Lindau Disease?

TL;DR: Von Hippel-Lindau (VHL) disease is a multisystem genetic disorder characterized by the growth of both benign and malignant tumors, most commonly hemangioblastomas in the central nervous system and retina, and clear cell renal cell carcinomas. Symptoms vary widely depending on the location and size of these tumors, requiring lifelong, proactive surveillance to manage potential complications.

What are the most common symptoms of Von Hippel-Lindau disease?

The clinical presentation of Von Hippel-Lindau disease is highly variable because the condition causes tumors to grow in various organs throughout the body. The most common and characteristic symptoms are driven by the development of hemangioblastomas (tumors consisting of blood vessels). These are frequently found in the cerebellum, spinal cord, and retina. Retinal hemangioblastomas often manifest as vision loss or blurred vision, while cerebellar tumors can cause headaches, dizziness, ataxia (loss of coordination), and vomiting due to increased intracranial pressure. Additionally, patients with Von Hippel-Lindau disease are at a significantly higher risk for pheochromocytomas—adrenal gland tumors that can lead to episodic high blood pressure, palpitations, and severe sweating.

What are the early warning signs to watch for?

Early identification of Von Hippel-Lindau disease is critical for long-term health outcomes. Families should remain vigilant for "red flag" symptoms that may indicate a new tumor growth, including:

• Visual changes: Persistent blurred vision, blind spots, or floaters, which may indicate a retinal hemangioblastoma.


• Neurological shifts: Unexplained balance issues, tremors, or persistent, worsening headaches that do not respond to standard treatment.


• Hypertensive episodes: Sudden spikes in blood pressure, especially in younger individuals, which may be a sign of a pheochromocytoma.


• Auditory symptoms: Hearing loss or ringing in the ears (tinnitus), which can occur if tumors develop in the endolymphatic sac of the inner ear.

How does disease progression affect quality of life?

Because Von Hippel-Lindau disease is a lifelong, progressive condition, the impact on quality of life is cumulative. Symptoms are often episodic; for example, a patient may be asymptomatic for years before a new tumor reaches a size that causes systemic effects. The most significant burdens on daily life often stem from the need for frequent surveillance imaging (MRI/CT scans) and the psychological stress of "scanxiety." Furthermore, repeated surgeries to remove tumors in the brain or spine can lead to lasting neurological deficits, while renal involvement may eventually necessitate nephrectomy or other kidney-preserving procedures.

When should you seek immediate medical attention?

Patients diagnosed with Von Hippel-Lindau disease should seek emergency medical care if they experience acute neurological deficits, such as sudden weakness in a limb, loss of vision in one eye, severe and sudden "thunderclap" headaches, or hypertensive crises (dangerously high blood pressure accompanied by chest pain or confusion). Prompt intervention is essential, as these symptoms may indicate a hemorrhage or acute pressure changes within the central nervous system.

Next steps

• Consult a clinical geneticist to confirm your diagnosis and discuss family screening protocols.


• Establish a care team that includes a neurologist, ophthalmologist, urologist, and endocrinologist.


• Join our DiseaseMaps.org community of over 100 individuals living with Von Hippel-Lindau disease to share experiences and coping strategies.


• Maintain a strict adherence to your annual screening schedule, as early detection is the primary defense against the progression of Von Hippel-Lindau disease.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH GARD: Von Hippel-Lindau disease overview.


• Orphanet: Clinical practice guidelines for the management of VHL.


• OMIM: Genetic profile and allelic variants of the VHL gene.


• VHL Alliance: Patient resources and clinical trial information.